We provide you with 20 years of free, institutional-grade data for ELAN stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of ELAN. Explore the full financial landscape of ELAN stock.
Reported Date | CIK | Ticker | Type | |
---|---|---|---|---|
2025-08-07 | 1739104 | ELAN | 10-Q | Url |
2025-05-07 | 1739104 | ELAN | 10-Q | Url |
2025-02-25 | 1739104 | ELAN | 10-K | Url |
2024-11-07 | 1739104 | ELAN | 10-Q | Url |
2024-08-08 | 1739104 | ELAN | 10-Q | Url |
2024-05-08 | 1739104 | ELAN | 10-Q | Url |
2024-02-26 | 1739104 | ELAN | 10-K | Url |
2023-11-07 | 1739104 | ELAN | 10-Q | Url |
2023-08-07 | 1739104 | ELAN | 10-Q | Url |
2023-05-09 | 1739104 | ELAN | 10-Q | Url |
2023-03-01 | 1739104 | ELAN | 10-K | Url |
2022-11-08 | 1739104 | ELAN | 10-Q | Url |
2022-08-08 | 1739104 | ELAN | 10-Q | Url |
2022-05-09 | 1739104 | ELAN | 10-Q | Url |
2022-02-28 | 1739104 | ELAN | 10-K | Url |
2021-11-05 | 1739104 | ELAN | 10-Q | Url |
2021-08-09 | 1739104 | ELAN | 10-Q | Url |
2021-05-07 | 1739104 | ELAN | 10-Q | Url |
2021-03-01 | 1739104 | ELAN | 10-K | Url |
2020-11-06 | 1739104 | ELAN | 10-Q | Url |
2020-07-30 | 1739104 | ELAN | 10-Q | Url |
2020-05-07 | 1739104 | ELAN | 10-Q | Url |
2020-02-28 | 1739104 | ELAN | 10-K | Url |
2019-11-08 | 1739104 | ELAN | 10-Q | Url |
2019-08-13 | 1739104 | ELAN | 10-Q | Url |
2019-05-14 | 1739104 | ELAN | 10-Q | Url |
2019-02-20 | 1739104 | ELAN | 10-K | Url |
2018-11-08 | 1739104 | ELAN | 10-Q | Url |
2018-08-02 | 1739104 | ELAN | S-1 | Url |
Elanco Animal Health Incorporated(NYSE:ELAN)


Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto...
Website: http://www.elanco.com
Founded: 1954
Full Time Employees: 6,080
CEO: Jeff Simmons
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic
The information provided in this report about ELAN stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.